In crowded field of psychedelic startups, Filament CEO makes case for ‘natural’ drugs
By MATTHEW PERRONE AP Health Writer More drugmakers are seeking to harness the medical potential of psychedelics for treating depression, addiction and other hard-to-treat conditions. In this crowded field, Vancouver-based Filament Health has a unique approach: extracting drugs from natural sources, including mushrooms, rather than synthesizing the ingredients in a laboratory. Filament is studying its
Continue Reading